These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7032949)

  • 1. Pharmacokinetics of prednisolone and endogenous hydrocortisone levels in cushingoid and non-cushingoid patients.
    Frey FJ; Amend WJ; Lozada F; Frey BM; Holford NH; Benet LZ
    Eur J Clin Pharmacol; 1981; 21(3):235-42. PubMed ID: 7032949
    [No Abstract]   [Full Text] [Related]  

  • 2. Endogenous hydrocortisone, a possible factor contributing to the genesis of cushingoid habitus in patients on prednisone.
    Frey FJ; Amend WJ; Lozada F; Frey BM; Benet LZ
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1076-80. PubMed ID: 7026594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous and exogenous glucocorticoids in cushingoid patients.
    Benet LZ; Frey FJ; Amend WJ; Lozada F; Frey BM
    Drug Intell Clin Pharm; 1982 Nov; 16(11):863-8. PubMed ID: 6756849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients.
    Bergrem H; Jervell J; Flatmark A
    Kidney Int; 1985 Feb; 27(2):459-64. PubMed ID: 3887001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients.
    Gambertoglio JG; Vincenti F; Feduska NJ; Birnbaum J; Salvatierra O; Amend WJ
    J Clin Endocrinol Metab; 1980 Sep; 51(3):561-5. PubMed ID: 6997330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different prednisolone pharmacokinetics in Cushingoid and non-Cushingoid kidney transplant patients.
    Bergrem H; Jervell J; Flatmark A
    Proc Eur Dial Transplant Assoc; 1983; 20():286-90. PubMed ID: 6361740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of assessing prednisolone pharmacokinetics before and after renal transplantation.
    Ost L; Björkhem I; von Bahr C
    Eur J Clin Pharmacol; 1984; 26(3):363-9. PubMed ID: 6376143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploratory study of total and free prednisolone plasma exposure and cushingoid appearance, quality of life and biochemical toxicity in adult male kidney transplant recipients.
    Bergmann TK; Isbel NM; Ostini R; Barraclough KA; Campbell SB; McWhinney BC; Inder WJ; Russell A; Staatz CE
    Clin Drug Investig; 2015 Nov; 35(11):743-50. PubMed ID: 26403249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of prednisolone in renal transplant patients with or without Cushing's syndrome].
    Demotes-Mainard F; Potaux L; Aparicio M; de Précigout V; Vinçon G; Albin H
    Therapie; 1986; 41(6):449-54. PubMed ID: 3544323
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of patient compliance in outpatient steroid treatment of nephrologic disease and renal transplant recipients.
    Hesse UJ; Roth B; Knuppertz G; Wienand P; von Lilien T
    Transplant Proc; 1990 Aug; 22(4):1405-6. PubMed ID: 2389340
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetics of prednisolone and endogenous cortisol suppression in the elderly.
    Stuck AE; Frey BM; Frey FJ
    Clin Pharmacol Ther; 1988 Apr; 43(4):354-62. PubMed ID: 3356080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy.
    Shibasaki H; Nakayama H; Furuta T; Kasuya Y; Tsuchiya M; Soejima A; Yamada A; Nagasawa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):164-9. PubMed ID: 18387858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid liquid-chromatographic method for simultaneous determination of plasma prednisone, prednisolone, and cortisol in pediatric renal-transplant recipients.
    McBride JH; Rodgerson DO; Park SS; Reyes AF
    Clin Chem; 1991 May; 37(5):643-6. PubMed ID: 2032316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study on the activity and side-effects of hydrocortisone, prednisolone, triamcinolone and dexamethasone].
    Fiegel G
    Clin Ter; 1976 Jul; 78(2):99-109. PubMed ID: 1087600
    [No Abstract]   [Full Text] [Related]  

  • 15. A sensitive high-pressure liquid chromatographic method for the determination of prednisone, prednisolone and hydrocortisone in plasma.
    Ağabeyoğlu IT; Wagner JG; Kay DR
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):163-76. PubMed ID: 7394312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednisolone clearance: a possible determinant for glucocorticoid efficacy in patients with oral vesiculo-erosive diseases.
    Lozada F; Frey FJ; Benet LZ
    J Dent Res; 1983 May; 62(5):575-7. PubMed ID: 6573375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays.
    Meikle AW; Weed JA; Tyler FH
    J Clin Endocrinol Metab; 1975 Oct; 41(4):717-21. PubMed ID: 1176582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked alterations in dose-dependent prednisolone kinetics in women taking oral contraceptives.
    Legler UF; Benet LZ
    Clin Pharmacol Ther; 1986 Apr; 39(4):425-9. PubMed ID: 3956058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous Cushing syndrome from an unexpected source of systemic steroids.
    O'Brien KF; DeKlotz CMC; Silverman RA
    Pediatr Dermatol; 2018 May; 35(3):e196-e197. PubMed ID: 29574945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.
    Schalm SW; Summerskill WH; Go VL
    Gastroenterology; 1977 May; 72(5 Pt 1):910-3. PubMed ID: 849821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.